Clin2
NCT07747389Possibly a fitNot yet recruiting

Lumateperone for major depressive disorder

Depressive Disorder, Major

Treatments studied

Part of Mental health clinical trials.

This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
585 people
Ages
18 years to 74 years
Study type
Interventional

Who can take part

  • You have been diagnosed with major depressive disorder (MDD), with or without previous episodes.
  • Your depression is moderate to severe, based on a doctor's assessment and a questionnaire.
  • You are medically stable, with no major health problems found in a physical exam, blood tests, or heart check.
  • You have not had thoughts of harming yourself or others recently, and no suicide attempts in the past 6 months.
  • You have not had a substance or alcohol use disorder in the past 6 months.
  • You have not had problems taking antidepressant medications as prescribed in the past.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05850689Recruiting· Phase 3
Lumateperone add-on for major depression that didn’t improve

This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.

Huntsville, Alabama
NCT07623135Recruiting· Phase 3
Lumateperone for Hard-to-Treat Depression in Older Adults

This study tests lumateperone, a new medication added to your current antidepressant, to help treat depression that hasn't improved with other treatments. It's designed for people age 60 and older who have tried at least two antidepressants without success.

Tucson, Arizona
NCT06372964Recruiting· Phase 3
Lumateperone for pediatric bipolar depression

This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.

Dothan, Alabama
NCT07699445Not yet recruiting· Phase 4
Lumateperone for weight and mood in bipolar depression

This study tests if lumateperone, a medication for bipolar depression, can also help with weight and aging in people with obesity. You may qualify if you have bipolar I depression and a body mass index (BMI) over 30.

Boston, Massachusetts
NCT07369115Not yet recruiting· Phase 4
Lumateperone for depression with early life trauma

This study tests whether adding lumateperone to your current antidepressant can help treat major depression that hasn't improved enough, especially if you experienced physical or sexual abuse before age 16. You'll have MRI scans and take the study drug for several weeks.

Austin, Texas
NCT06482554Recruiting· Phase 3
Lumateperone for Apathy in Psychotic Disorders

This trial tests a medication called lumateperone to see if it can improve apathy (lack of motivation) in people who have psychotic symptoms from schizophrenia or related disorders. It may help if you are already on a stable treatment but still struggle with apathy.

Shreveport, Louisiana

Hear when a new Depressive Disorder, Major trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.